Late Toxicity in High-risk Prostate Cancer Treated with Androgen Suppression and Hypofractionated Intensity Modulated Radiotherapy

被引：1
|
作者：
Drodge, S. [1 ]
Pervez, N. [1 ]
Ghosh, S. [1 ]
Mackenzie, M. [1 ]
Yee, D. [1 ]
Mihai, A. [1 ]
Murtha, A. [1 ]
Amanie, J. [1 ]
Fallone, G. [1 ]
Pearcey, R. [1 ]
机构：
[1] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.834
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S353 / S353
页数：1
相关论文
共 50 条
  • [41] Moderately Hypofractionated Radiotherapy and Androgen Deprivation Therapy for High-risk Localised Prostate Cancer: Predictors of Long-term Biochemical Control and Toxicity
    Maulik, S.
    Arunsingh, M.
    Arun, B.
    Prasath, S.
    Mallick, I
    CLINICAL ONCOLOGY, 2022, 34 (01) : E52 - E60
  • [42] Whole pelvic intensity-modulated radiotherapy for high-risk prostate cancer: a preliminary report
    Joo, Ji Hyeon
    Kim, Yeon Joo
    Kim, Young Seok
    Choi, Eun Kyung
    Kim, Jong Hoon
    Lee, Sang-wook
    Song, Si Yeol
    Yoon, Sang Min
    Kim, Su Ssan
    Park, Jin-hong
    Jeong, Yuri
    Ahn, Hanjong
    Kim, Choung-Soo
    Lee, Jae-Lyun
    Do Ahn, Seung
    RADIATION ONCOLOGY JOURNAL, 2013, 31 (04): : 199 - 205
  • [43] Two Different Intensity-modulated Radiotherapy Strategies for Patients with High-risk Prostate Cancer
    De Felice, Francesca
    Musio, Daniela
    Caiazzo, Rossella
    Panebianco, Valeria
    Raffetto, Nicola
    Tombolini, Vincenzo
    ANTICANCER RESEARCH, 2014, 34 (07) : 3747 - 3751
  • [44] Conventional versus hypofractionated intensity-modulated radiotherapy for Prostate cancer
    Pahl, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (09) : 841 - 842
  • [45] Hypofractionated intensity-modulated radiotherapy effective in localized prostate cancer
    Alexandra King
    Nature Clinical Practice Urology, 2006, 3 (2): : 69 - 69
  • [46] Hypofractionated intensity-modulated radiotherapy effective in localized prostate cancer
    Alexandra King
    Nature Clinical Practice Oncology, 2006, 3 (2): : 65 - 66
  • [47] Intensity-modulated Radiotherapy (80 Gy) in Low, Intermediate, and High-risk Prostate Cancer: Factors Influencing Relapse and Toxicity
    Charissoux, M.
    Moscardo, C. Llacer
    Thezenas, S.
    Fenoglietto, P.
    Ailleres, N.
    Segui, B.
    Rebillard, X.
    Hay, M.
    Dubois, J.
    Azria, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S642 - S642
  • [48] Evolution in late rectal toxicity in prostate cancer patients in the intensity modulated radiotherapy era
    Fonteyne, V. F.
    Sadeghi, S. S.
    Ost, P. O.
    De Meerleer, G. D. M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S33 - S33
  • [49] Intermediate Risk Prostate Cancer Treated with Hypofractionated External Beam Radiotherapy without Androgen Deprivation: Preliminary Results and Toxicity Analysis
    Dal Pra, A. L.
    Faria, S.
    Cury, F.
    David, M.
    Duclos, M.
    Shenouda, G.
    Souhami, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S189 - S189
  • [50] Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer
    Houben, Jeroen
    McColl, Gill
    Kaanders, Johannes Ham
    Smeenk, Robert J.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 29 : 40 - 46
12345